These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6205530)

  • 1. Tumor marker studies of cervical smears. Potential for automation.
    Moncrieff D; Ormerod MG; Coleman DV
    Acta Cytol; 1984; 28(4):407-10. PubMed ID: 6205530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunocytochemical staining of cervical smears for the diagnosis of cervical intraepithelial neoplasia.
    Moncrieff D; Ormerod MG; Coleman DV
    Anal Quant Cytol; 1984 Sep; 6(3):201-5. PubMed ID: 6391321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An immunohistochemical study of the distribution of epithelial antigens in the uterine cervix.
    Bamford PN; Ormerod MG; Sloane JP; Warburton MJ
    Obstet Gynecol; 1983 May; 61(5):603-8. PubMed ID: 6188081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor marker studies of cervical smears: an immunohistochemical approach.
    Sarker AB; Koirala TR; Nose S; Jeon HJ; Hoshida Y
    Indian J Pathol Microbiol; 1994 Jan; 37(1):45-51. PubMed ID: 7522221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards an automated procedure for the quantitative cytological screening of cervical neoplasms.
    Sincock AM; Middleton J; Moncrieff D
    J Clin Pathol; 1983 May; 36(5):535-8. PubMed ID: 6841647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia.
    Liao SY; Stanbridge EJ
    Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):549-57. PubMed ID: 8827360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automated screening of cervical smears using immunocytochemical staining: a possible approach.
    Valkova B; Laurence DJ
    J Clin Pathol; 1985 Aug; 38(8):886-92. PubMed ID: 2411765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [An immunohistochemical study of the distribution of epithelial membrane antigen (EMA) in uterine carcinoma].
    Fukuda K; Fujimoto I; Masubuchi K
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 May; 39(5):739-45. PubMed ID: 3598270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial membrane antigen in cells from the uterine cervix: immunocytochemical staining of cervical smears.
    Valkova B; Ormerod MG; Moncrieff D; Coleman DV
    J Clin Pathol; 1984 Sep; 37(9):984-9. PubMed ID: 6206101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of atypical glandular cells of uncertain significance in cervical cytologic smears.
    Korn AP; Judson PL; Zaloudek CJ
    J Reprod Med; 1998 Sep; 43(9):774-8. PubMed ID: 9777615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical and vaginal cytologic smears suggestive of adenocarcinoma.
    Pretorius R; Binstock M; Sadeghi M; Hodges W
    J Reprod Med; 1996 Jul; 41(7):478-82. PubMed ID: 8829059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescent studies directed towards the location of abnormal epithelial cells in cervical smears.
    Steven FS; Johnson J
    Cytopathology; 1990; 1(4):217-22. PubMed ID: 1714306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The significance of endocervical cells in the vaginal smear and a new technic for the collection of endocervical smears].
    Boon ME; Alons van Kordelaar JJ
    Ned Tijdschr Geneeskd; 1986 Mar; 130(12):557. PubMed ID: 3960172
    [No Abstract]   [Full Text] [Related]  

  • 14. [A falsely reassuring cervical smear in adenocarcinoma of the external os].
    Rooker D; Baalbergen A; Helmerhorst TJ
    Ned Tijdschr Geneeskd; 2008 Apr; 152(17):977-80. PubMed ID: 18549169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Less pap-2 results ('minor abnormalities') in the population screening for cervical cancer since the introduction of new guidelines in 1996].
    Bos AB; van Ballegooijen M; van den Akker-van Marle ME; Habbema JD
    Ned Tijdschr Geneeskd; 2002 Aug; 146(34):1586-90. PubMed ID: 12224483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
    Schindeler S; Morrell S; Zuo Y; Baker D
    J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical and ultrastructural study of skull base chordomas.
    Kubota T; Sato K; Kabuto M; Kawano H; Nakagawa T; Arai Y; Tachibana O; Yoshida K; Yamashita J
    Noshuyo Byori; 1994; 11(1):23-8. PubMed ID: 7512866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic marker displays for intermediate cells from the uterine cervix.
    Bartels PH; Bibbo M; Dytch HE; Pishotta FT; Yamauchi K; Wied GL
    Acta Cytol; 1982; 26(1):29-34. PubMed ID: 6950623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early detection of precursors of cervical cancer with cervical cytology and visual inspection of cervix with acetic Acid.
    Dhaubhadel P; Vaidya A; Choudhary P
    JNMA J Nepal Med Assoc; 2008; 47(170):71-6. PubMed ID: 18709035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of immunohistochemical markers in the diagnosis of cervical neoplasia.
    Fray RE; Husain OA; To AC; Watts KC; Lader S; Rogers GT; Taylor-Papadimitriou J; Morris NF
    Br J Obstet Gynaecol; 1984 Oct; 91(10):1037-41. PubMed ID: 6386038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.